Keeping Up with the Diabetes Technology: 2016 Endocrine Society Guidelines of Insulin Pump Therapy and Continuous Glucose Monitor Management of Diabetes-Reference-Cited by-同舟云学术

Keeping Up with the Diabetes Technology: 2016 Endocrine Society Guidelines of Insulin Pump Therapy and Continuous Glucose Monitor Management of Diabetes

Published:2017-09-23 Issue:11 Volume:17 Page:
ISSN:1534-4827
Container-title:Current Diabetes Reports
language:en
Short-container-title:Curr Diab Rep

Author:

Galderisi Alfonso,Schlissel Elise,Cengiz Eda

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://link.springer.com/article/10.1007/s11892-017-0944-6/fulltext.html

Reference51 articles.

1. Nathan DM, Genuth S, Lachin J, Cleary P, Crofford O, Davis M, et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977–86.

2. Tamborlane WV, Beck RW, Bode BW, Buckingham B, Chase HP, Clemons R, et al. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med. 2008;359(14):1464–76.

3. •• Bergenstal RM, Tamborlane WV, Ahmann A, Buse JB, Dailey G, Davis SN, et al. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med. 2010;363(4):311–20. The results of the landmark clinical trial demonstrated that sensor-augmented pump therapy improves glycemic control significantly in adult and pediatric subjects with inadequately controlled type 1 diabetes as compared to insulin therapy.

4. Panel FCCaCTD. FDA Executive Summary. Dexcom G5 Mobile Continuous Glucose Monitoring System, Dexcom, Inc. July 21, 2016 meeting of the Clinical Chemistry and Clinical Toxicology Devices Panel P120005/S041.

5. Peters AL, Ahmann AJ, Battelino T, Evert A, Hirsch IB, Murad MH, et al. Diabetes technology-continuous subcutaneous insulin infusion therapy and continuous glucose monitoring in adults: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2016;101(11):3922–37.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of a biomimetic hydrogel depot technology for sustained delivery of GLP-1 receptor agonists reduces burden of diabetes management;Cell Reports Medicine;2023-11

2. Sustained Delivery of GLP-1 Receptor Agonists from Injectable Biomimetic Hydrogels Improves Treatment of Diabetes;2023-01-30

3. Continuous glucose monitoring for the prevention of morbidity and mortality in preterm infants;Cochrane Database of Systematic Reviews;2021-12-21

4. Continuous Blood Glucose Monitoring Increases Vigorous Physical Activity Levels and Is Associated With Reduced Hypoglycemia Avoidance Behavior In Youth With Type 1 Diabetes;Frontiers in Endocrinology;2021-09-07

5. Parents' experiences on the combined use of continuous subcutaneous insulin infusion and real‐time continuous glucose monitoring to manage Type 1 diabetes in their children: A systematic review and meta‐synthesis of qualitative studies;Nursing Open;2021-06-30